Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Russell L. Rothman, Thomas G. Stewart, Ahmad Mourad, David R. Boulware, Matthew W. McCarthy, Florence Thicklin, Idania T. Garcia del Sol, Jose Luis Garcia, Carolyn T. Bramante, Nirav S. Shah, Upinder Singh, John C. Williamson, Paulina A. Rebolledo, Prasanna Jagannathan, Tiffany Schwasinger-Schmidt, Adit A. Ginde, Mario Castro, Dushyantha Jayaweera, Mark Sulkowski, Nina Gentile, Kathleen McTigue, G. Michael Felker, Allison DeLong, Rhonda Wilder, Sean Collins, Sarah E. Dunsmore, Stacey J. Adam, George J. Hanna, Elizabeth Shenkman, Adrian F. Hernandez, Susanna Naggie, Christopher J. Lindsell, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators
medRxiv 2024.05.16.24307115; doi: https://doi.org/10.1101/2024.05.16.24307115